Overview
Biowet Puławy is a Polish pharmaceutical company that has manufactured veterinary medicines since 1920. It specializes in medicines against bee varroosis and vaccines for animals, and provides analytical and manufacturing services.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 43 days early. All were audited by a statutory auditor.
- 202506/07/2026
- 202409/06/2025
- 202313/06/2024
- 202207/06/2023
- 202122/06/2022
- 202018/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Public procurement
Biowet Puławy is the contractor in 13 public sector contracts, worth USD 13.59k in total. They were signed with 13 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 26, 2026 | Bovituberculin | $2,506 | Inspekcja Weterynaryjna Powiatowy Inspektorat Weterynarii | |
| Oct 13, 2026 | Purchase of bovine tuberculin | $400.19 | Powiatowy Inspektorat Weterynarii w Jarosławiu | |
| Oct 9, 2026 | Purchase of BOVITUBERCULIN | $2,451 | Powiatowy Inspektorat Weterynarii w Poznaniu |
Trademarks
Biowet Puławy holds 28 active trademarks registered with the Polish Patent Office. 35 marks have expired or were not registered. The first mark was filed in 1990.
| Mark | Protected until | |
|---|---|---|
| MASTIPREWENT | Nov 21, 2032 | |
| POXVAC | Nov 21, 2032 | |
| REHYDRAT | Nov 21, 2032 | |
| APTOVAC(word) | Oct 2, 2030 | |
| BOVIKETOZIN(word) | May 24, 2030 |
Authorized Representatives
Manner of representation
For making declarations of will concerning property rights and obligations and for signing agreements and other documents on behalf of the company, the joint action of two members of the management board or of a member of the management board with a commercial proxy is required.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Edmund Wiktor Giedrojćage 65 | 1,136 | $44,801.73 | 13.7864% |
Marta Grażyna Grzędaage 72 | 882 | $34,784.44 | 10.7039% |
Others | 6,222 | $245,384.12 | 75.5097% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1996-07-02.
48 1030 1508 0000 0008 2410 8004
56 2490 0005 0000 4600 0020 3506
25 1020 3147 0000 8002 0080 2181
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $201.3K$201,299 |
Buildings and premises | $5M$4,998,133 |
Public aid
8 public aid cases recorded, with a total value of $1,732,064.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 8, 2025 | Investment aid for energy efficiency projects in buildings | $618.3K$618,257 | Prezes Banku Gospodarstwa Krajowego | |
| Dec 8, 2025 | Investment aid for the promotion of energy from renewable sources | $511K$511,050 | Prezes Banku Gospodarstwa Krajowego | |
| Dec 8, 2025 | Investment aid for energy efficiency measures | $32,459$32,459 | Prezes Banku Gospodarstwa Krajowego |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $2,178,790.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-10-30 | Investments improving energy efficiency at Biowet Puławy sp. z o. o. | $1.2M$1,166,788 | European Funds for a Modern Economy | |
| 2019-01-14 | Implementation of an innovative technology for producing the PMV-1 antigen | $123.7K$123,670 | Regional Operational Programme of the Lubelskie Voivodeship for 2014-2020 | |
| 2018-05-02 | Increasing the company's competitiveness through the introduction of new veterinary preparations into production | $433.1K$433,070 | Regional Operational Programme of the Lubelskie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Integrated permit | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| US Pharmaciasp. z o.o. | $41,267,631.19 | uspharmacia.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl | ||
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A. | $14,322,437.53 | ewa-sa.pl | ||
| Biofaktorsp. z o.o. | $10,761,755.73 | biofaktor.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-18 | Share capital increase (1,202,700.00 PLN → 1,203,040.00 PLN) | |
| 2001-11-26 | Entered in the register |
FAQ
Last updated: 2026-07-09